Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2021   142,745,021      
Balance at the beginning at Dec. 31, 2021 $ 290,274 $ 14 $ 396,064 $ 0 $ (105,804)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,896,975 1,894,179      
Issuance of common stock upon exercise of stock options $ 828 $ 1 827    
Issuance of common stock upon vesting of restricted stock units (in shares)   565,774      
Issuance of common stock upon exercise of warrants 0        
Stock-based compensation cost 22,299   22,299    
Cumulative translation adjustment (10)     (10)  
Net loss (86,406)       (86,406)
Balance at the end (in shares) at Dec. 31, 2022   145,204,974      
Balance at the end at Dec. 31, 2022 $ 226,985 $ 15 419,190 (10) (192,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,735,978 1,735,978      
Issuance of common stock upon exercise of stock options $ 668 $ 0 668    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,265,155      
Issuance of common stock upon exercise of warrants (in shares)   1,103,973      
Issuance of common stock upon exercise of warrants 464   464    
Stock-based compensation cost 24,503   24,503    
Cumulative translation adjustment (43)     (43)  
Net loss (106,254)       (106,254)
Balance at the end (in shares) at Dec. 31, 2023   151,310,080      
Balance at the end at Dec. 31, 2023 $ 146,323 $ 15 $ 444,825 $ (53) $ (298,464)